Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCH-A1 international study for adult Langerhans cell histiocytosis
2006-002392-40Phase 2Active
- Sponsor
- VU University Medical Center
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of prednisone, vinblastine and mercaptopurine in Langerhans cell histiocytosis (LCH) and pulmonary Langerhans cell histiocytosis (PLCH), sponsored by VU University Medical Center. Primary endpoints: Uniform treatment definition and implementation, Uniform evaluation and stratification criteria and 1 more. Started Aug 2007; status: active.
02
Drugs
prednisonevinblastinemercaptopurine
03
Conditions
Langerhans cell histiocytosis (LCH)pulmonary Langerhans cell histiocytosis (PLCH)
Beyond the preview
Go deeper on 2006-002392-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002392-40.